CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 28 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $717,671 | -3.8% | 379,720 | -25.1% | 0.00% | – |
| Q2 2023 | $745,716 | -37.2% | 507,290 | -16.7% | 0.00% | – |
| Q1 2023 | $1,187,614 | +84487.9% | 609,033 | -2.4% | 0.00% | – |
| Q4 2022 | $1,404 | -99.9% | 623,871 | +0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,503,000 | +15.4% | 623,867 | -0.5% | 0.00% | – |
| Q2 2022 | $1,302,000 | -27.2% | 627,200 | -1.1% | 0.00% | -100.0% |
| Q1 2022 | $1,788,000 | -41.3% | 633,904 | -2.9% | 0.00% | 0.0% |
| Q4 2021 | $3,047,000 | +62.0% | 652,561 | -6.3% | 0.00% | 0.0% |
| Q3 2021 | $1,881,000 | -12.5% | 696,654 | -7.8% | 0.00% | 0.0% |
| Q2 2021 | $2,149,000 | -3.9% | 755,500 | +2.4% | 0.00% | 0.0% |
| Q1 2021 | $2,236,000 | -2.7% | 737,881 | -5.6% | 0.00% | 0.0% |
| Q4 2020 | $2,299,000 | -10.4% | 781,891 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $2,565,000 | -7.3% | 798,954 | -3.8% | 0.00% | 0.0% |
| Q2 2020 | $2,766,000 | -10.6% | 830,687 | -2.6% | 0.00% | -50.0% |
| Q1 2020 | $3,095,000 | -30.2% | 852,622 | -0.9% | 0.00% | 0.0% |
| Q4 2019 | $4,431,000 | -13.1% | 860,319 | +0.0% | 0.00% | 0.0% |
| Q3 2019 | $5,100,000 | -7.2% | 860,088 | -0.3% | 0.00% | 0.0% |
| Q2 2019 | $5,497,000 | +8.0% | 862,919 | -1.5% | 0.00% | 0.0% |
| Q1 2019 | $5,091,000 | -8.2% | 876,239 | -0.5% | 0.00% | -33.3% |
| Q4 2018 | $5,546,000 | +10.6% | 880,248 | +0.2% | 0.00% | +50.0% |
| Q3 2018 | $5,015,000 | -6.2% | 878,348 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $5,349,000 | -9.3% | 872,674 | -1.2% | 0.00% | 0.0% |
| Q1 2018 | $5,899,000 | -10.5% | 883,085 | -0.6% | 0.00% | -33.3% |
| Q4 2017 | $6,592,000 | +7.1% | 888,411 | +1.9% | 0.00% | 0.0% |
| Q3 2017 | $6,157,000 | +0.5% | 872,087 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $6,125,000 | +2.2% | 866,283 | +0.3% | 0.00% | 0.0% |
| Q1 2017 | $5,995,000 | +27.8% | 863,819 | +1.3% | 0.00% | +50.0% |
| Q4 2016 | $4,691,000 | +10.1% | 852,976 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $4,259,000 | +11.3% | 850,185 | -0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,827,000 | -0.0% | 850,507 | -0.2% | 0.00% | 0.0% |
| Q1 2016 | $3,828,000 | -14.8% | 852,511 | -0.2% | 0.00% | -33.3% |
| Q4 2015 | $4,491,000 | -8.6% | 853,836 | +0.2% | 0.00% | 0.0% |
| Q3 2015 | $4,916,000 | -19.5% | 851,964 | -0.2% | 0.00% | -25.0% |
| Q2 2015 | $6,104,000 | +8.2% | 853,647 | +0.8% | 0.00% | 0.0% |
| Q1 2015 | $5,642,000 | +10.7% | 847,135 | -0.3% | 0.00% | +33.3% |
| Q4 2014 | $5,098,000 | +21.6% | 849,686 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $4,193,000 | +8.8% | 848,839 | -0.9% | 0.00% | 0.0% |
| Q2 2014 | $3,855,000 | +16.8% | 856,581 | +16.8% | 0.00% | +50.0% |
| Q1 2014 | $3,300,000 | -11.4% | 733,379 | +0.6% | 0.00% | -33.3% |
| Q4 2013 | $3,725,000 | +11.7% | 729,006 | -1.0% | 0.00% | 0.0% |
| Q3 2013 | $3,336,000 | -11.5% | 736,409 | -0.2% | 0.00% | -25.0% |
| Q2 2013 | $3,770,000 | – | 737,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 188,703 | $557,000 | 0.43% |
| Sterling Financial Planning, Inc. | 22,031 | $65,000 | 0.05% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 165,495 | $488,000 | 0.04% |
| Ariel Investments | 821,096 | $2,422,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,287 | $445,000 | 0.01% |
| Renaissance Technologies | 675,159 | $1,992,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 781,891 | $2,299,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $9,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 105,018 | $310,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 53,441 | $157,000 | 0.00% |